Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,089 | 34,326 | 49,656 | 21,364 | 62,888 |
| Marketable Securities | 132,569 | 61,904 | 66,294 | 117,643 | 131,951 |
| Receivables | 11,779 | 2,384 | 2,334 | 2,183 | 47,447 |
| Inventories | 276 | 281 | 158 | 168 | 201 |
| TOTAL | $186,032 | $101,895 | $122,527 | $145,084 | $245,806 |
| Non-Current Assets | |||||
| PPE Net | 1,753 | 1,863 | 1,981 | 2,132 | 2,308 |
| Intangibles | 44,543 | 44,543 | 44,543 | 44,543 | 44,543 |
| Other Non-Current Assets | 36,491 | 36,686 | 36,876 | 33,824 | 5,014 |
| TOTAL | $82,787 | $83,092 | $83,400 | $80,499 | $51,865 |
| Total Assets | $268,819 | $184,987 | $205,927 | $225,583 | $297,671 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 4,595 | N/A | N/A | 42,056 |
| Accounts payable and accrued liabilities | 2,996 | 3,083 | 3,797 | 5,899 | 10,689 |
| Accrued Expenses | 6,902 | 13,189 | 13,620 | 11,481 | 12,948 |
| TOTAL | $9,898 | $20,867 | $21,720 | $34,836 | $110,693 |
| Non-Current Liabilities | |||||
| Long Term Debt | 49,684 | 49,408 | 56,508 | 56,107 | 58,643 |
| Deferred Revenues | N/A | N/A | 4,303 | 17,456 | 45,000 |
| Other Non-Current Liabilities | 6,381 | 7,174 | 7,540 | 5,200 | 5,303 |
| TOTAL | $56,065 | $56,582 | $64,048 | $61,307 | $63,946 |
| Total Liabilities | $65,963 | $77,449 | $85,768 | $96,143 | $174,639 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 444,196 | 423,681 | 363,399 | 363,399 | 363,178 |
| Common Shares | 426 | 366 | 366 | 366 | 366 |
| Retained earnings | -2,018,626 | -2,017,583 | -2,002,054 | -1,989,285 | -1,992,537 |
| Other shareholders' equity | 31 | -157 | -158 | -201 | -162 |
| TOTAL | $202,856 | $107,538 | $120,159 | $129,440 | $123,032 |
| Total Liabilities And Equity | $268,819 | $184,987 | $205,927 | $225,583 | $297,671 |